Immune Cells Derived from Stem Cells May Reverse Age-Related Brain Changes and Alzheimer’s Signs
New research shows that youthful immune cells derived from stem cells can reverse signs of brain aging and improve memory in mouse models, promising potential therapies for neurodegenerative diseases.
Researchers at Cedars-Sinai Medical Center have discovered that 'young' immune cells, generated from human stem cells, can reverse signs of aging and neurodegeneration in the brains of laboratory mice. Published in the journal Advanced Science, this preclinical study highlights the potential of harnessing immune cell therapy to combat cognitive decline associated with aging and Alzheimer's disease.
The study focused on mononuclear phagocytes—immune cells responsible for clearing harmful substances from the body, which typically decline in effectiveness with age. Scientists used pluripotent stem cells, which are adult cells reverted to an early embryonic state, to produce youthful versions of these immune cells. When infused into aging mice or models of Alzheimer’s, these cells produced notable improvements.
Mice treated with these young immune cells demonstrated better memory performance in behavioral tests and showed increased numbers of mossy cells in the hippocampus—a critical region for learning and memory. Additionally, the microglia, which act as the brain’s resident immune cells, remained healthier with more extensive branching, indicating preserved function.
Interestingly, the young immune cells did not appear to directly enter the brain, suggesting their beneficial effects might be mediated through indirect mechanisms, such as releasing protective proteins or extracellular vesicles into the bloodstream that influence brain health.
This research opens the door for developing personalized immune cell therapies from stem cells, offering an unlimited source of treatment candidates. The findings suggest that short-term interventions with these cells could significantly improve cognition and neural health, paving the way for future clinical trials in humans.
The study's authors believe that such therapies could provide promising new strategies for addressing age-related cognitive decline and neurodegenerative diseases like Alzheimer’s, by restoring immune function and brain health.
For more details, see the original publication in Advanced Science: DOI: 10.1002/advs.202417848.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Advanced Biological Aging Clock Surpasses Existing Models in Predicting Mortality and Health Outcomes
A new biological aging clock called LinAge2 outperforms existing models in predicting mortality and health outcomes, offering a promising tool for personalized aging assessment and healthy longevity strategies.
Enhancing Stroke Rehabilitation Through Stronger Policies for Better Patient Outcomes
A new American Heart Association policy advocates for stronger public policies to close gaps in stroke rehabilitation care, ensuring equitable access for all survivors and improving recovery outcomes.
Blood Stem Cell Mutations and Their Potential Role in Reducing Alzheimer's Disease Risk
Research reveals that mutations in blood stem cells, particularly in the TET2 gene, may significantly reduce the risk of late-onset Alzheimer's disease by enhancing brain immune responses.
Understanding how male and female muscle metabolism influences diabetes risk
New research highlights the distinct metabolic behaviors of male and female muscles, revealing implications for tailored strategies to prevent and treat diabetes. Discover how sex differences influence muscle function and metabolic health.